UBS Group’s Flexion Therapeutics, Inc. FLXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-1,979
Closed -$12K 11336
2021
Q3
$12K Hold
1,979
﹤0.01% 7847
2021
Q2
$16K Sell
1,979
-21,702
-92% -$185K ﹤0.01% 7617
2021
Q1
$211K Buy
23,681
+14,671
+163% +$168K ﹤0.01% 5448
2020
Q4
$104K Buy
9,010
+1,202
+15% +$14K ﹤0.01% 5667
2020
Q3
$81K Sell
7,808
-4,715
-38% -$57.8K ﹤0.01% 5307
2020
Q2
$165K Sell
12,523
-131
-1% -$1.36K ﹤0.01% 4936
2020
Q1
$100K Sell
12,654
-7,130
-36% -$107K ﹤0.01% 5298
2019
Q4
$410K Sell
19,784
-89,743
-82% -$1.51M ﹤0.01% 5019
2019
Q3
$1.5M Buy
109,527
+49,739
+83% +$590K ﹤0.01% 3588
2019
Q2
$736K Buy
59,788
+38,129
+176% +$440K ﹤0.01% 3984
2019
Q1
$270K Sell
21,659
-259,054
-92% -$3.46M ﹤0.01% 4426
2018
Q4
$3.18M Buy
280,713
+209,392
+294% +$3.28M ﹤0.01% 2584
2018
Q3
$1.33M Buy
71,321
+19,760
+38% +$454K ﹤0.01% 3579
2018
Q2
$1.33M Sell
51,561
-124,950
-71% -$3.24M ﹤0.01% 3529
2018
Q1
$3.96M Buy
176,511
+132,279
+299% +$3.23M ﹤0.01% 2527
2017
Q4
$1.11M Buy
44,232
+11,153
+34% +$273K ﹤0.01% 3702
2017
Q3
$799K Buy
33,079
+15,450
+88% +$363K ﹤0.01% 3876
2017
Q2
$357K Buy
17,629
+14,954
+559% +$311K ﹤0.01% 4363
2017
Q1
$72K Sell
2,675
-1,027
-28% -$21K ﹤0.01% 5276
2016
Q4
$70K Buy
3,702
+1,197
+48% +$22.9K ﹤0.01% 5564
2016
Q3
$49K Sell
2,505
-69
-3% -$1.17K ﹤0.01% 5542
2016
Q2
$39K Buy
2,574
+2,255
+707% +$28.3K ﹤0.01% 5718
2016
Q1
$3K Buy
+319
New +$3.87K ﹤0.01% 7233
2015
Q4
Sell
-68
Closed -$1K 8667
2015
Q3
$1K Sell
68
-130
-66% -$3.05K ﹤0.01% 8261
2015
Q2
$4K Buy
+198
New +$3.99K ﹤0.01% 8005
2015
Q1
Sell
-1,125
Closed -$23K 9605
2014
Q4
$23K Buy
+1,125
New +$20.4K ﹤0.01% 7463